| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| No Relationships to Disclose |
|
|
| Honoraria |
| No Relationships to Disclose |
|
|
| Consulting or Advisory Role |
| No Relationships to Disclose |
|
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: Corcept Therapeutics |
| Recipient: Your Institution |
| Company: Abbvie |
| Recipient: Your Institution |
| Company: Iovance Biotherapeutics |
| Recipient: Your Institution |
| Company: Sermonix Pharmaceuticals |
| Recipient: Your Institution |
| Company: Compugen |
| Recipient: Your Institution |
| Company: Roche |
| Recipient: Your Institution |
| Company: Celldex |
| Recipient: Your Institution |
| Company: Molecular Templates |
| Recipient: Your Institution |
| Company: Astellas Pharma |
| Recipient: Your Institution |
| Company: K Group beta |
| Recipient: Your Institution |
| Company: AstraZeneca |
| Recipient: Your Institution |
| Company: Compugen |
| Recipient: Your Institution |
| Company: Merck |
| Recipient: Your Institution |
| Company: Incyte |
| Recipient: Your Institution |
| Company: P{fizer |
| Recipient: Your Institution |
| Company: Artios |
| Recipient: Your Institution |
| Company: Duality Biologics |
| Recipient: Your Institution |
| Company: Sanofi |
| Recipient: Your Institution |
| Company: Pheast Therapeutics |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Open Payments Link |
| not answered |
|
|